Summary. Nineteen sulphonamides and related drugs were screened for their antifertility effects in male rats. They were suspended in corn oil and fed orally to rats at 10 times the human dose for a period of 6 months. Of the 19 compounds tested, sulphamethazine, sulphapyridine, dapsone, sulphamethoxypyridazine, sulphaguanidine, sulphathizole, sulphamerazine and sulphadimethoxine reduced fecundity of male rats to 34\m=.\3,37\m=.\6, 38\m=.\3,53\m=.\6,55\m=.\6,58, 75 and 78\m=.\6%of control, respectively. The fall in fecundity was due to a reduction in the number of embryos compared with the number of corpora lutea per pregnant female, and, in some cases, was associated with a fall in epididymal sperm concentration and motility. Some of these compounds accumulated in the cauda epididymidis at concentrations equal to or higher than the free drug concentrations in the blood. It is proposed that the antifertility effects of some of these compounds may in part be mediated through a direct effect on epididymal stored spermatozoa, hence compromising some processes vital for fertilization.
Introduction
Although sulphasalazine has been used for a long time to control inflammatory bowel diseases (Svartz, 1942; Dissanayake & Truelove, 1973) , it was only recently realized that it also has an antifertility effect in men. Infertility is associated with a decrease in sperm count and motility and an increased number of abnormal sperm forms (Levi et al, 1979; Toth, 1979) . The antifertility effect is reversible and is reproducible in experimental animals Pholpramool & Srikhao, 1983; O'Morain et al, 1985) . Sulphasalazine undergoes azo reduction to 5-aminosalicyclic acid and sulphapyridine in the gut (Peppercorn & Goldman, 1972) . The latter appears to be respon¬ sible for the antifertility effect of sulphasalazine (Toovey et al, 1981; O'Morain et al, 1984) . In the rat, sulphasalazine and sulphapyridine treatment do not affect hormone profile, testis weight and histology, or sperm concentration in the epididymis (Pholpramool & Srikhao, 1983; O'Morain et al, 1984) . These, together with the rapid onset of action and recovery after drug withdrawal indicate that the site of action is the epididymis. However, epididymal functions appeared not to be altered after sulphasalazine treatment (Chodorge et al, 1986) .
In this work we have studied the effects of 19 compounds (including sulphapyridine) on the fertility and fecundity of male rats. Their effects on the viability of epididymal spermatozoa and their penetration into the epididymis were also studied.
Materials and Methods
Animals. Sprague-Dawley rats were obtained from the Laboratory Animal Unit of the University of Hong Kong. They were reared and maintained under SPF conditions at an ambient temperature of 20 + 1°C and a relative humidity of 60-80%. Drug treatment. Nineteen compounds were studied in 5 consecutive fertility trials each consisting of 3 or 4 test compounds over a period of 12 months (Table 1) . Each test compound was freshly suspended in corn oil and was fed via gastric intubation into a group of 6-12 male rats weighing about 300 g at the start of the treatment. The dosage used was 10 times the human dose (Table 1) and treatment was for 6 weeks. Each trial also contained a group of 6-12 control rats to which corn oil only was fed. The body weight of each rat was taken before each feeding. (Wong & Lee, 1982) . Paraffin oil was infused into the lumen of the epididymis using a Harvard infusion pump, displacing the contents into a calibrated polythene tubing (Portex 800/100/260/100; i.d. 0-86 mm) inserted into the vas.
Sperm motility assessment. A small portion of the epididymal content (about 1 µ in 2 mm length of tubing) was suspended in 3 ml oxygenated medium (Wong et al, 1981) containing (mM): NaCl, 138; KC1,4-7; CaCl2,2-56, MgS04, 113; Tris (pH 7-2), 5; BSA, 0-2%; and glucose, 0-2%. The solution had a calculated osmolarity of 295 mosmol/1. The spermatozoa were incubated in this solution at 34°C for 1 min, after which 40 µ of the suspension was spread onto a prewarmed glass slide and covered with a prewarmed cover-slip and observed under a microscope ( 100 magnification) equipped with dark-field illumination. In the earlier experiments, sperm motility was assessed visually, but in most experiments motility was measured objectively using time-lapse photography. Three random fields were photographed (ASA 400, exposure time 1 sec). The forward velocity was determined by analysis from the projected images of the negatives the vector distance of the progressing spermatozoa, with the aid of a digitizer and an IBM personal computer. 'Forward Motility Index' was calculated from the mean velocity (pm/sec) % motile spermatozoa (Wong et al, 1981 Blood sera and epididymal plasmas were filtered through a micropartition system fitted with a YMT filtration membrane (Amicon Danvers, MA, U.S.A.) to separate the free (unbound) drugs from the bound (to proteins) drugs. To the filtrates so obtained (~5 0 µ ) and the epididymal plasmas (5-20 µ were added 250 µ acetate buffer (1 m, pH 4-7), 10 µ internal standards (sulfamethoxazole for sulphapyridine and dapsone assays; dapsone for trimethoprim, sulpha¬ methizole and sulphamerazine assays) and 3 ml solvents (chloroform for dapsone, trimethoprim, sulphamethoxazole, sulphapyridine and sulphamethizole assays; acetone/ether (1:2, v/v) for sulphamerazine assay) and agitated for 2 h and then centrifuged at 3000 g for 15 min. The separated organic phase was evaporated to complete dryness under reduced pressure and redissolved in 50 µ acetonitrile/water (20/80 v/v) and 10 µ injected into the HPLC system. The concentrations of drugs in blood sera and epididymal plasmas were quantified by calculating the peak area ratios of the drug to the added internal standard and relating them to a previously constructed calibration curve obtained from sera containing different amounts of the drug (Fischer & Klotz, 1978) . The recoveries of the assays ranged from 60 to 90%.
The drugs were obtained from Sigma (St Louis, MO, U.S.A.) except for frusemide and tolbutamide which were gifts from the International Organization for Chemical Sciences in Development (IOCD).
Statistical analysis. Differences between treated and control groups were compared by using an analysis of variance. All data are presented as mean + s.e.m.
Results
Effects on fertility and fecundity Of the 19 compounds tested, sulphaguanidine, sulphapyridine, dapsone, sulphamethazine, sulphamethoxypyridazine, sulphathiazole, sulphamerazine and sulphadimethoxine reduced the fecundity of male rats by significantly reducing the embryo number over corpus luteum number per pregnant female ( Table 2 ). The numbers of female rats impregnated by the males treated with sulphapyridine, dapsone, sulphamethazine, sulphathiazole and sulphamethoxypyridazine were also reduced (Table 1) . If the percentage of pregnant females was taken into account in the expres¬ sion of the 'Fecundity Index' (see 'Materials and Methods'), then sulphapyridine, dapsone and sulphamethazine reduced fecundity by more than 50% compared with normal rats. The other 11 compounds tested had no effect on fecundity of male rats (Table 2) . Effects on sperm concentration and motility As shown in Table 3 , frusemide, pyrimethamine, sulphapyridine and sulphaguanidine signifi¬ cantly reduced sperm concentration by 9, 22, 20 and 17%, respectively. The capacity to initiate forward motility of the cauda epididymal spermatozoa was reduced by dapsone (by 30%), propranolol (by 38%), sulphamerazine (by 49%) and sulphamethoxypyridazine (by 64%).
Effect on body weight
Some of the compounds administered caused a fall in body weight when measured at the end of the dosage period (Table 3) . These drugs included sulphamerazine, pyrimethamine and sulpha¬ dimethoxine. Of these sulphamerazine and sulphadimethoxine possessed an antifertility effect ( (Fig. 1) . The concentrations of these compounds in blood sera and epididymal plasmas were calculated from the chromatograms (see 'Methods') and are given in Table 4 . The concentrations of dapsone and sulphamethizole in epididymal plasmas approached those in blood sera after 6 weeks treatment with the drugs. Sulphapyridine, sulpha¬ merazine and sulphamethoxazole accumulated in the epididymis at concentrations about 2-4 times higher than the free drug concentrations in blood sera. The concentration of trimethoprim in the epididymal plasma was significantly lower than that in blood serum.
In some experiments, unilateral efferent duct ligation was performed in male rats before treatment with sulphapyridine (321 mg/kg/day). After treatment for 7 days, blood serum and epididymal 96-7+11-6(6) "192-3 + 17-1(6) Sulphamerazine 75-0 16-8 ± 1-3 (7) "72-9 ± 7-6(7) Dapsone 38-3 1-9+ 0-3 (8) 2-9+ 1-2(7) Sulphamethoxazole -* 2-4 ± 1-0 (6) 11-4 ± 3-8(6) Sulphamethizole -* 1-3+ 0-3 (7) 1-4+ 0-4(7)
Trimethoprim -* 3-6 ± 0-9 (7) "0-7 ± 0-4 (6) (Walker, 1944; Minguet, 1947) . Cotrimoxazole, a sulphonamide-containing mixture, and dapsone, a sulphonamide-related molecule, were also found to impair semen quality (Murdia et al, 1978) . To date, nothing is known about the basis of the antifertility effects of these compounds.
The 19 compounds tested represent a diverse group of drugs which are commonly used for their antimicrobial, antibacterial, hypoglycaemic, diuretic and antihypertensive effects. Some of the sulphonamides are structurally related to sulphapyridine which has been shown to possess an antifertility effect in male rats Pholpramool & Srikhao, 1983; O'Morain et al, 1985) . Of these 19 compounds, sulphapyridine, sulphaguanidine, sulphamerazine, sulphamethazine, sulphathizole, sulphamethoxypyridazine, sulphadimethoxine and dapsone reduced the fecundity of male rats to 37-6, 55-6, 75, 34-3, 58, 53-6, 78-6 and 38-3% of control, respectively (Table 2) . Our results are consistent with previous findings that sulphapyridine reduced fecundity of male rats by reducing the number of live fetuses in each pregnant female but had no effect on epididymal sperm motility (O'Morain et al, 1985) .
The present data do not allow us to identify the site of action of the 8 compounds that had an antifertility effect. They could act by inhibiting gonadotrophin secretion, by suppressing spermato¬ genesis, or by interfering with sperm maturation and storage. Cosentino et al. (1984) and Chodorge et al. (1986) (Tables 2 & 3 ) had no effect on fertility. Sperm motility was apparently normal after sulphapyridine, sulphamethazine, sulphathizole and sulphaguanidine treatment despite a fall in fecundity in the male rats treated with these compounds (Table 3) .
The epididymis has been shown to secrete para-aminohippurate (PAH) from blood into lumen by a probenecid-sensitive pathway (Qiu & Wong, 1985) . Since PAH is the prototype of drugs which are actively secreted by the renal tubular cells, it is likely that the epididymis also secretes other organic acids by the same pathway. To test whether some of these compounds are secreted by the epididymal cells, we measured the accumulation of 6 of them in the epididymal fluid (Fig. 1) (Table 4) .
It seems that the blood-epididymis barrier can discriminate amongst various drug molecules with regard to their permeation into the epididymal lumen. The three sulphonamides, although sulphapyridine, sulphamerazine and sulphamethoxazole all penetrated into the epididymis, only sulphapyridine and sulphamerazine were effective in reducing fecundity. Although there is no direct relationship between the antifertility efficacy and the degree of accumulation in the epididymis (epididymal fluid concentration over blood concentration), there is some indication that their presence in the epididymis is a prerequisite for an antifertility effect. Trimethoprim which permeated the blood-epididymis barrier poorly was inactive (Table 5) .
We therefore suggest that the presence of drug molecules in the epididymis was at least partly responsible for the antifertility action of sulphapyridine, sulphamerazine and dapsone. After access into the epididymal compartment, the drugs could bind to sperm membranes and affect capacitation, the acrosome reaction, or any post-testicular event that is essential for the successful penetration of the oocyte. Spermatozoa of animals and men treated with sulphasalazine or sulphapyridine display larger heads or 'mégalo' head forms which may reflect a direct damaging effect of the drugs on the sperm acrosomal membrane (Toth, 1979; Hudson et al, 1982) .
Spermatozoa from hamsters fed with sulphasalazine have normal metabolism and motility, and yet are unable to undergo the acrosome reaction or penetrate hamster eggs in vitro (O'Morain et al, 1985) . Chodorge et al, (1986) reported that sulphasalazine did not alter the composition of the epididymal 'milieu' and hence epididymal functions. The lesion produced by sulphasalazine seems to reside on the sperm membrane; an increase in sperm membrane lipid peroxidation after sulpha¬ salazine treatment has been described (see Chodorge et al, 1986 ). These observations are in accord with a direct effect on epididymal spermatozoa of sulphasalazine or its metabolite, sulphapyridine which enters the epididymis through transport across the blood-epididymis barrier.
